mRNA-1195

N/A

Report date: 2026/05/13 11:17:45

Base Information

Drug NamemRNA-1195

Drug Alias NamemRNA-1195

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMultiple SclerosisEpstein-Barr Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustraliaUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc

Inactive CompaniesN/A

Active IndicationsMultiple SclerosisEpstein-Barr Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A